JW Shinyak is a subsidiary of JW Pharmaceutical. They also focus on the development of innovative new drugs with new technology. Their major pipelines are Atopic Dermatitis (Furestem-AD®; Phase 3), Osteoarthritis (Furestem-OA Kit Inj.; Phase1/2a), Rheumatoid Arthritis (Furestem-RA®; Phase2b), and Organoid (Skin, Pancreatic Islets).
| Contact Details | JW Gwacheon Tower, 38, Gwacheon-daero 7-gil, Gwacheon-si, Gyeonggi-do, 13840, Republic of KoreaTel +82-2-2109-3300 |
|---|
